VIS
REGN icon

Vega Investment Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Vega Investment Solutions’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Sell
2,057
-10,631
-84% -$8.14M 0.38% 32
2025
Q4 		$9.79M Buy
+12,688
New +$8.62M 1.56% 12

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vega Investment Solutions's REGN Position: Q1 2026 in Review

Vega Investment Solutions reduced its Regeneron Pharmaceuticals (REGN) stake by 84% in Q1 2026, selling an estimated $8.14M and leaving 2,057 shares worth $1.59M. The position accounts for 0.38% of the portfolio, ranked #32.

Vega Investment Solutions first reported a position in REGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $9.79M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Vega Investment Solutions held 2,057 shares of Regeneron Pharmaceuticals worth $1.59M as of Q1 2026.
  • Vega Investment Solutions sold 10,631 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $8.14M.
  • Regeneron Pharmaceuticals made up 0.38% of Vega Investment Solutions's portfolio in Q1 2026, its #32 holding.
  • Vega Investment Solutions first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Vega Investment Solutions's Regeneron Pharmaceuticals position peaked at $9.79M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Vega Investment Solutions's 13F filing for Q1 2026, filed 14 May 2026.